Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warfarin
Pharma
Octapharma secures FDA nod for warfarin reversal agent Balfaxar
The FDA signed off on Octapharma's blood coagulant Balfaxar as a treatment to counter the effects of commonly used blood thinner warfarin.
Kevin Dunleavy
Jul 26, 2023 3:15pm
Takeda offloads $670M of European drugs
Apr 24, 2020 12:17pm
J&J, Bayer's Xarelto scores FDA nod in acutely ill patients
Oct 14, 2019 12:19pm
New Pfizer, BMS real-world data could boost Eliquis in Europe
Sep 1, 2019 5:00am
BMS, Pfizer's Eliquis tops warfarin in high-risk afib group
Mar 17, 2019 11:47am
BMS, Pfizer's Eliquis to unseat warfarin in 'weeks': exec
Jul 30, 2018 10:31am
